(Alliance News) - Mediclinic International PLC on Thursday said it expects a full-year revenue rise in Southern African operations following positive trading.
The firm, which ends its financial year in March, forecasts annual growth in Mediclinic South Africa of 6.5%. This would leave the unit with revenue of GBP943.6 million, up from GBP886 million last year.
The earnings before interest, tax, depreciation, and amortisation margin, pre-IFRS16, is expected at roughly 20%, Mediclinic said. The adjusted Ebitda margin was 21.2% last year.
Mediclinic added it has made IT and staff investments during the year and expects a lower margin contribution from a facility in Stellenbosch, in South Africa's Western Cape.
The statement came ahead of the company hosting analysts and investors at a site visit in Cape Town.
During the visit, Southern Africa Chief Executive Koert Pretorius will address the firm's strategic objectives, how to deliver growth in Southern Africa, and how it can navigate the region's "regulatory environment".
Mediclinic shares were 2.0% higher in Johannesburg on Thursday morning at ZAR75.48. In London, the stock was trading 1.9% higher at 392.10 pence.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
